Clinical Trial Update: Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers

View source ↗

Summary

MD Anderson Cancer Center is conducting a study to determine if liquid biopsies and tumor molecular profiling can predict recurrence in various endometrial canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Endometrial Clear Cell Carcinoma
• Endometrial Dedifferentiated Carcinoma
• Endometrial Mucinous Adenocarcinoma
• Endometrial Serous Carcinoma
• Uterine Corpus Carcinosarcoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma | Status: RECRUITING